Sixty seconds on . . . psilocybin
BMJ May 18, 2016 DOI: 10.1136/bmj.i2775 via OpenAlex
Summary
AI-generated from the abstractA study in London found that psilocybin, the active ingredient in magic mushrooms, may be effective against treatment-resistant depression. Effects appeared quickly, within a week, and over 40% of treated patients remained in remission three months later. The patients had depression that had not responded to other treatments.
Study at a glance
| Characteristics | Observational study Peer reviewed |
|---|---|
| Population | Patients with treatment-resistant depression |
| Intervention | Psilocybin |
| Duration | Three-month follow-up |
| Topics | Psilocybin |
| Keywords | Magic telescope Depression economics Psychology Psychoanalysis |
| Citations | 5 |
| Key finding | Psilocybin may be effective against treatment-resistant depression, with over 40% of patients in remission three months after treatment. |
Abstract
Not so fast. There’s a long way to go. But a study in London has shown that the active ingredient in magic mushrooms, psilocybin, may be effective against treatment resistant depression. Its effects were quick—within a week—and more than 40% of the patients treated were still in remission three months later.1 Yes, as far as it goes. These were people whose depression had …